NCT01460706View on ClinicalTrials.gov

Imaging Malignant Glioma With 68Ga-DOTATOC PET/CT

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
Glioma
Interventions
DRUG

[68Ga]DOTATOC

120MBq 68Ga-DOTATOC intravenously and PET/CT imaging. Performed once to a patient before the surgery.

Trial Locations (1)

FI-21100

Turku PET Centre, Turku University Hospital, Turku

All Listed Sponsors
lead

Turku University Hospital

OTHER_GOV

NCT01460706 - Imaging Malignant Glioma With 68Ga-DOTATOC PET/CT | Biotech Hunter | Biotech Hunter